CN Stock MarketDetailed Quotes
000919 Jinling Pharmaceutical
- 7.16
- -0.40-5.29%
Trading Dec 17 13:40 CST
4.47BMarket Cap60.68P/E (TTM)
7.54High7.09Low450.44KlotVolume7.44Open7.56Pre Close327.02MTurnover7.63%Turnover Ratio44.75P/E (Static)623.71MShares8.1452wk High1.18P/B4.23BFloat Cap5.2852wk Low8.32Limit Up590.36MShs Float29.05Historical High6.80Limit Down5.95%Amplitude0.09Historical Low0.10Dividend TTM7.26Avg Price272.64KlotAsk1.40%Div YieldTTM100Lot Size173.47KlotBid
Jinling Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 3.83%2.04B | 7.03%1.42B | -4.85%625.43M | 0.77%2.81B | -3.52%1.97B | 1.71%1.33B | 6.55%657.35M | -3.28%2.79B | -0.96%2.04B | -5.78%1.31B |
| Refunds of taxes and levies | ---- | ---- | ---- | 1,762.65%395.9K | ---- | ---- | ---- | --21.25K | ---- | ---- |
| Cash received relating to other operating activities | -48.63%45.91M | -35.00%29.11M | -33.94%12.17M | 206.55%87.58M | 245.19%89.38M | 103.85%44.79M | 86.03%18.42M | -13.42%28.57M | -9.55%25.89M | 24.78%21.97M |
| Cash inflows from operating activities | 1.55%2.09B | 5.66%1.45B | -5.65%637.6M | 2.87%2.89B | -0.40%2.06B | 3.40%1.38B | 7.81%675.76M | -3.39%2.81B | -1.08%2.07B | -5.40%1.33B |
| Goods services cash paid | 1.22%1.11B | -0.84%730.06M | -16.43%332.81M | 8.28%1.5B | 3.53%1.09B | 18.83%736.25M | 28.49%398.22M | -9.32%1.39B | -3.47%1.06B | 4.17%619.61M |
| Staff behalf paid | 5.62%767.24M | 10.44%538.57M | 21.24%293.84M | 5.64%956.39M | 6.58%726.45M | -16.25%487.64M | -23.02%242.36M | 9.44%905.34M | 13.84%681.62M | 8.58%582.29M |
| All taxes paid | -33.88%65.81M | -39.45%42.72M | -45.51%13.53M | 21.59%118.78M | 25.72%99.54M | 20.48%70.56M | -18.77%24.82M | -6.14%97.69M | -0.91%79.18M | 4.06%58.56M |
| Cash paid relating to other operating activities | 5.51%153.39M | 39.12%104.36M | 64.29%58.67M | -2.94%156.98M | 35.07%145.39M | 7.83%75.01M | -18.74%35.71M | 2.38%161.74M | 1.97%107.63M | 28.56%69.56M |
| Cash outflows from operating activities | 1.38%2.09B | 3.38%1.42B | -0.32%698.84M | 7.14%2.74B | 7.28%2.07B | 2.97%1.37B | 0.26%701.12M | -2.57%2.55B | 2.46%1.93B | 7.14%1.33B |
| Net cash flows from operating activities | 46.31%-3.98M | 512.39%37.81M | -141.55%-61.24M | -39.01%158.92M | -105.24%-7.41M | 1,393.62%6.17M | 65.01%-25.35M | -10.76%260.59M | -32.74%141.23M | -99.75%413.35K |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -37.51%163.42M | --145.32M | --100.13M | 41.22%421.53M | 60.98%261.53M | ---- | ---- | 11.85%298.5M | 160.68%162.46M | 253.67%91.96M |
| Cash received from returns on investments | -19.80%11.35M | 24.08%7.46M | 16.84%2.9M | -25.42%18.91M | 87.36%14.15M | -4.99%6.02M | 12.05%2.49M | -13.75%25.35M | -17.97%7.55M | -47.88%6.33M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 218.31%807.27K | 110.96%490.05K | -82.09%31.3K | -70.50%23.62M | -99.03%253.61K | 137.57%232.3K | 180.72%174.79K | 23.29%80.06M | 801.74%26.07M | -94.87%97.78K |
| Cash inflows from investing activities | -36.37%175.58M | 2,353.18%153.27M | 3,773.61%103.07M | 14.89%464.06M | 40.72%275.93M | -93.65%6.25M | -4.32%2.66M | 11.83%403.9M | 167.95%196.08M | 153.51%98.38M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -25.36%112.19M | 3.92%89.09M | -38.69%25.77M | -39.85%186.25M | -23.89%150.32M | -48.70%85.74M | -72.11%42.04M | 90.24%309.64M | 1.73%197.5M | 8.70%167.13M |
| Cash paid to acquire investments | 19.65%771.8M | 318.71%711.8M | 58.12%268.8M | 120.69%647.96M | 49.13%645.06M | -53.03%170M | -45.60%170M | 10.25%293.6M | 31.63%432.55M | 28.22%361.95M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --21.77M | --20.55M | ---- |
| Cash outflows from investing activities | 11.14%883.99M | 213.17%800.89M | 38.93%294.57M | 33.47%834.21M | 22.25%795.39M | -51.66%255.74M | -54.22%212.04M | 45.25%625.02M | 24.46%650.6M | 21.33%529.09M |
| Net cash flows from investing activities | -36.38%-708.42M | -159.58%-647.62M | 8.54%-191.5M | -67.40%-370.16M | -14.29%-519.45M | 42.07%-249.49M | 54.53%-209.38M | -219.89%-221.11M | -1.10%-454.52M | -8.42%-430.7M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | 21,882.82%742.63M | 21,882.82%742.63M | 21,882.82%742.63M | -71.98%7.88M | -87.98%3.38M | -88.19%3.38M | -85.70%3.38M | --28.12M | --28.12M | --28.62M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | 0.00%4.5M | ---- | ---- | ---- | --4.5M | ---- | --5M |
| Cash from borrowing | ---- | ---- | ---- | -84.47%305K | -73.64%305K | 1,185.87%6.3M | --303.33K | -86.91%1.96M | -92.29%1.16M | --490K |
| Cash received relating to other financing activities | ---- | ---- | ---- | --6.6M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | 20,062.47%742.63M | 7,572.62%742.63M | 20,071.60%742.63M | -50.84%14.79M | -87.42%3.68M | -66.75%9.68M | -84.41%3.68M | 100.53%30.08M | 95.15%29.27M | --29.11M |
| Borrowing repayment | ---- | ---- | ---- | -91.53%1.78M | -95.37%971.88K | -71.43%6M | ---- | --21M | --20.99M | --20.99M |
| Dividend interest payment | 16.81%62.28M | 9,153.93%62.19M | 67.38%21.93K | -0.35%53.33M | -0.57%53.32M | 571.76%672.07K | -83.96%13.1K | 0.46%53.52M | 1.25%53.62M | -95.48%100.05K |
| -Including:Cash payments for dividends or profit to minority shareholders | -96.10%84.35K | ---- | ---- | -7.62%2.17M | -12.07%2.16M | ---- | ---- | -9.90%2.35M | -3.94%2.46M | ---- |
| Cash payments relating to other financing activities | -79.55%325K | -71.48%325K | ---- | 61.06%2.95M | 115.61%1.59M | --1.14M | ---- | 33.44%1.83M | 952.23%736.97K | ---- |
| Cash outflows from financing activities | 12.03%62.6M | 700.59%62.52M | 67.38%21.93K | -23.96%58.06M | -25.84%55.88M | -62.97%7.81M | -99.91%13.1K | 39.71%76.34M | 42.09%75.35M | 853.59%21.09M |
| Net cash flows from financing activities | 1,402.89%680.03M | 36,268.70%680.11M | 20,143.04%742.61M | 6.48%-43.27M | -13.27%-52.19M | -76.67%1.87M | -57.02%3.67M | -16.69%-46.26M | -21.16%-46.08M | 462.44%8.02M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 148.21%12.4K | 318.53%49.42K | 148.85%13.3K | -76.17%19.02K | -161.19%-25.73K | ---22.61K | -7,476.65%-27.23K | 7,180.75%79.82K | 14,342.46%42.05K | ---- |
| Net increase in cash and cash equivalents | 94.41%-32.35M | 129.14%70.35M | 311.99%489.88M | -3,693.08%-254.48M | -61.16%-579.08M | 42.82%-241.47M | 55.93%-231.09M | -103.66%-6.71M | -29.43%-359.32M | -80.04%-422.27M |
| Add:Begin period cash and cash equivalents | -17.25%1.22B | -17.25%1.22B | -17.25%1.22B | -0.45%1.47B | -0.45%1.47B | -0.45%1.47B | -0.45%1.47B | 14.11%1.48B | 14.11%1.48B | 14.11%1.48B |
| End period cash equivalent | 32.62%1.19B | 4.65%1.29B | 37.50%1.71B | -17.25%1.22B | -20.18%895.81M | 16.43%1.23B | 29.94%1.24B | -0.45%1.47B | 9.95%1.12B | -0.42%1.06B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
